Whittier Trust Co. of Nevada Inc. Sells 84 Shares of Humana Inc. (NYSE:HUM)

Whittier Trust Co. of Nevada Inc. trimmed its stake in shares of Humana Inc. (NYSE:HUM) by 45.4% in the fourth quarter, Holdings Channel.com reports. The fund owned 101 shares of the insurance provider’s stock after selling 84 shares during the quarter. Whittier Trust Co. of Nevada Inc.’s holdings in Humana were worth $26,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors also recently made changes to their positions in the stock. FPC Investment Advisory Inc. bought a new position in Humana during the 4th quarter worth approximately $27,000. Centricity Wealth Management LLC bought a new position in Humana during the fourth quarter worth $30,000. LFA Lugano Financial Advisors SA lifted its holdings in Humana by 56.3% in the fourth quarter. LFA Lugano Financial Advisors SA now owns 125 shares of the insurance provider’s stock valued at $32,000 after buying an additional 45 shares during the period. OFI Invest Asset Management bought a new stake in Humana during the fourth quarter valued at $33,000. Finally, Atwood & Palmer Inc. grew its holdings in Humana by 64.5% during the 4th quarter. Atwood & Palmer Inc. now owns 153 shares of the insurance provider’s stock worth $39,000 after acquiring an additional 60 shares during the period. 92.38% of the stock is owned by institutional investors and hedge funds.

Humana Price Performance

Shares of NYSE:HUM opened at $271.65 on Tuesday. Humana Inc. has a 1-year low of $213.31 and a 1-year high of $406.46. The company has a current ratio of 1.76, a quick ratio of 1.76 and a debt-to-equity ratio of 0.68. The stock has a market cap of $32.79 billion, a PE ratio of 27.30, a price-to-earnings-growth ratio of 2.05 and a beta of 0.57. The stock’s fifty day simple moving average is $271.01 and its two-hundred day simple moving average is $275.60.

Humana (NYSE:HUM) last released its quarterly earnings results on Tuesday, February 11th. The insurance provider reported ($2.16) earnings per share for the quarter, beating analysts’ consensus estimates of ($2.26) by $0.10. Humana had a net margin of 1.02% and a return on equity of 11.70%. As a group, analysts forecast that Humana Inc. will post 16.47 EPS for the current fiscal year.

Humana Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, April 25th. Stockholders of record on Friday, March 28th will be issued a $0.885 dividend. This represents a $3.54 annualized dividend and a dividend yield of 1.30%. The ex-dividend date is Friday, March 28th. Humana’s dividend payout ratio is presently 35.58%.

Analyst Ratings Changes

Several brokerages recently commented on HUM. Piper Sandler upped their target price on Humana from $270.00 to $288.00 and gave the company a “neutral” rating in a research report on Wednesday, January 15th. Royal Bank of Canada reaffirmed an “outperform” rating and set a $283.00 price objective on shares of Humana in a research report on Wednesday, February 12th. Cantor Fitzgerald reiterated a “neutral” rating and set a $290.00 target price on shares of Humana in a research report on Wednesday, February 12th. StockNews.com cut shares of Humana from a “buy” rating to a “hold” rating in a report on Tuesday, March 18th. Finally, JPMorgan Chase & Co. dropped their price objective on shares of Humana from $257.00 to $256.00 and set a “neutral” rating on the stock in a report on Tuesday, February 18th. Eighteen investment analysts have rated the stock with a hold rating and five have assigned a buy rating to the company’s stock. According to data from MarketBeat, the company currently has a consensus rating of “Hold” and an average target price of $285.68.

Insider Activity at Humana

In other Humana news, insider Timothy S. Huval sold 3,703 shares of the company’s stock in a transaction on Tuesday, December 31st. The stock was sold at an average price of $256.26, for a total value of $948,930.78. Following the completion of the transaction, the insider now owns 8,181 shares in the company, valued at $2,096,463.06. This represents a 31.16 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. 0.37% of the stock is currently owned by company insiders.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.